 New York, New York--Newsfile Corp. - June 12, 2021 - Pomerantz LLP announces that a class action lawsuit has been filed against FibroGen, Inc. FibroGen or the Company NASDAQ: FGEN and certain of its officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 21-cv-03212, is on behalf of a class consisting of all persons and entities other than Defendants who purchased or... 